Vaishnaw Akshay (CIK 0001458494)

Latest company ownership

Shares held
616,205
Last filed at
May 30, 2025
Confidence Score
49.8
2025Q4
Confidence Score History
2025Q2 2025Q4
Shares held
11,707
Last filed at
Aug 14, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2013Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 29, 2025 May 30, 2025 Scholar Rock Holding Corp President Sell 45.0 -6,750 -1.08% ✓ $200.6K
Aug 3, 2023 Aug 7, 2023 ALNYLAM PHARMACEUTICALS, INC. President Sell 97.5 +4,884 26.54% ✗ $754K
Apr 26, 2023 Apr 28, 2023 ALNYLAM PHARMACEUTICALS, INC. President Sell 97.5 +2,920 18.86% ✗ $465.5K
Feb 10, 2023 Feb 14, 2023 ALNYLAM PHARMACEUTICALS, INC. President Sell 3.8 -38,044 -71.07% ✓ $8.2M
Dec 5, 2022 Dec 7, 2022 ALNYLAM PHARMACEUTICALS, INC. President Sell 20.0 -1,324 -5.53% ✗ $299.5K
Aug 3, 2022 Aug 5, 2022 ALNYLAM PHARMACEUTICALS, INC. President Sell 100.0 +7,131 60.79% ✗ $1.2M
Dec 21, 2021 Dec 23, 2021 ALNYLAM PHARMACEUTICALS, INC. President Sell 48.8 - 0.00% ✓ $1M
Aug 9, 2021 Aug 11, 2021 ALNYLAM PHARMACEUTICALS, INC. President Sell 5.0 -10,834 -48.01% ✓ $2.2M
Jun 18, 2021 Jun 22, 2021 ALNYLAM PHARMACEUTICALS, INC. President Sell 5.0 -14,708 -55.63% ✓ $2.6M
Apr 19, 2021 Apr 21, 2021 ALNYLAM PHARMACEUTICALS, INC. President Sell 10.0 -3,706 -20.21% ✓ $1.2M
Feb 11, 2021 Feb 16, 2021 ALNYLAM PHARMACEUTICALS, INC. President Sell 97.5 +3,706 25.32% ✗ $266.4K
Sep 29, 2020 Oct 1, 2020 ALNYLAM PHARMACEUTICALS, INC. President Sell 32.5 -971 -6.22% ✓ $135.9K
Jun 22, 2020 Jun 24, 2020 ALNYLAM PHARMACEUTICALS, INC. President Sell 32.5 -970 -6.22% ✓ $146.5K
Apr 20, 2020 Apr 22, 2020 ALNYLAM PHARMACEUTICALS, INC. President Sell 5.0 -21,971 -60.02% ✓ $3.1M
Apr 7, 2020 Apr 9, 2020 ALNYLAM PHARMACEUTICALS, INC. President Sell 97.5 +2,904 24.76% ✗ $263.4K
Feb 7, 2020 Feb 11, 2020 ALNYLAM PHARMACEUTICALS, INC. President Sell 5.0 -23,708 -66.90% ✓ $3M
Aug 13, 2018 Aug 14, 2018 ALNYLAM PHARMACEUTICALS, INC. President Sell 90.0 +1,015 8.79% ✗ $69.7K
Mar 14, 2018 Mar 16, 2018 ALNYLAM PHARMACEUTICALS, INC. President Sell 2.5 -88,554 -88.46% ✓ $12.7M
Oct 30, 2017 Nov 1, 2017 ALNYLAM PHARMACEUTICALS, INC. EVP, R&D Sell 5.0 -33,666 -73.93% ✓ $4.1M
Jun 13, 2017 Jun 15, 2017 ALNYLAM PHARMACEUTICALS, INC. EVP, R&D Sell 26.3 -430 -3.51% ✗ $32K
May 23, 2017 May 25, 2017 ALNYLAM PHARMACEUTICALS, INC. EVP, R&D Sell 7.5 -11,000 -50.97% ✓ $825K
May 15, 2017 May 17, 2017 ALNYLAM PHARMACEUTICALS, INC. SVP, R&D Sell 5.0 -43,750 -67.69% ✓ $2.8M
Dec 30, 2016 Jan 4, 2017 ALNYLAM PHARMACEUTICALS, INC. EVP, R&D Sell 22.5 -5,000 -32.22% ✗ $187.2K
Nov 30, 2016 Dec 2, 2016 ALNYLAM PHARMACEUTICALS, INC. EVP, R&D, CMO Sell 5.0 -29,165 -83.00% ✓ $1.3M
Jun 16, 2015 Jun 18, 2015 ALNYLAM PHARMACEUTICALS, INC. EVP, R&D, CMO Sell 5.0 -8,750 -98.84% ✓ $1.1M
Mar 17, 2015 Mar 19, 2015 ALNYLAM PHARMACEUTICALS, INC. EVP, R&D, CMO Sell 5.0 -8,750 -99.07% ✓ $1M
Dec 16, 2014 Dec 16, 2014 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Medical Officer Sell 7.5 -10,626 -99.23% ✓ $994.6K
Sep 16, 2014 Sep 17, 2014 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Medical Officer Sell 7.5 -10,625 -99.34% ✓ $765.5K
Jun 17, 2014 Jun 19, 2014 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Medical Officer Sell 7.5 -10,625 -99.67% ✓ $741.8K
Mar 18, 2014 Mar 20, 2014 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Medical Officer Sell 5.0 -32,769 -100.00% ✓ $2.4M
Feb 21, 2014 Feb 25, 2014 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Medical Officer Sell 22.5 -2,615 -100.00% ✗ $235.6K
Jan 23, 2014 Jan 27, 2014 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Medical Officer Sell 5.0 -12,588 -82.80% ✓ $1.1M
Dec 16, 2013 Dec 18, 2013 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Medical Officer Sell 5.0 -33,480 -33.25% ✓ $2M
Sep 10, 2013 Sep 12, 2013 ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Medical Officer Sell 7.5 -6,250 -29.09% ✓ $359.2K